SCOTUS Denies Bayer's Roundup Appeal

Earlier today, the Supreme Court of the United States denied Bayer’s appeal regarding the safety of its weedkiller, Roundup. The decision marks an end to the years-long legal battle to determine if Roundup causes cancer, and the company will likely be forced to pay billions of dollars to settle current and future lawsuits.

Bayer acquired Roundup maker Monsanto back in 2018 for $63 billion. Since then, the company has been buried in lawsuits claiming that glyphosate – the primary ingredient in Roundup – causes cancer. Bayer has lost more than 50% of its market value since the acquisition and stocks dipped by about 4% on news of the Supreme Court’s decision.

For the better part of a decade, we’ve talked about the extreme danger that glyphosate poses to public health. This was before Bayer – known for manufacturing aspirin and birth control – acquired Monsanto, a leading herbicide manufacturer. Glyphosate has been shown time and again to cause cancer, but Bayer made one final attempt to have those claims dismissed in court.

In August of 2021, a California appeals court upheld an $86 million verdict that found Bayer responsible for a couple’s cancer after using Bayer’s glyphosate-based Roundup against weeds. The court was abundantly clear about Bayer’s guilt in the case:

https://thetruthaboutcancer.com/scotus-denies-bayers-roundup-appeal/?mpweb=144-9742981-744685726

#SCOTUS #Denies #Bayer's #Roundup #Appeal